Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion type Assertion NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_head.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion wasGeneratedBy ECO_0000203 NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_provenance.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion wasDerivedFrom befree-20150227 NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_provenance.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion SIO_000772 23300058 NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_provenance.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion evidence source_evidence_literature NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_provenance.
- NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_assertion description "[Signaling activity in the PI3K and MAPK pathways was assessed by measuring intracellular levels of p-AKT and p-ERK at baseline and in response to pathway modulation; 66% (N = 19) of BC samples and 27% (N = 4) of NC samples met the 'evaluable' criteria, i.e., at least 400,000 total cells available upon sample receipt with >2% of cells showing an epithelial phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620737.RA4l8Onr73mOevqDWpz_7N2d3zYIZODG637O_fcQ1vLBg130_provenance.